GB Sciences Inc (GBLX)

[OTCRIDER]

GB Sciences Las Vegas Cultivation Facility

GB Sciences Nevada - Cultivation Facility
http://vimeo.com/110499518

GB Sciences Nevada, LLC (GBSN), is working to provide the citizens of Nevada with the highest-quality cannabinoid treatments. In June, 2014, GBSN received a special use permit to operate a cultivation center in Clark County, Nevada—the state’s first local jurisdiction to accept and approve applications for cannabis-related businesses. In November, 2014, the State of Nevada gave its approval

This 28,432-square-foot facility will contain 20,000 square feet of cultivation space to house GB Sciences’ proprietary technology system for growing medical-grade cannabis in the TissueBLOX™ (for immature plantlets), GrowBLOX™ (for mature plants), and CureBLOX™ (to ensure safe, efficacious drying). In addition, the facility will feature a 2,500-square-foot conversion lab for extracting and post-processing oil-based cannabinoid therapies, a security control room, a packaging room, employee facilities, and management offices.

LAS VEGAS, Nov 6, 2014 GrowBLOX Sciences, Inc., (“GB Sciences“) (GBLX), announced today that its majority-controlled Nevada applicant, GB Sciences Nevada, LLC, has received Nevada State approval to proceed with its special use permit to establish and operate a medical marijuana cultivation facility in Clark County.

GB Sciences Nevada did not receive approval from the State of Nevada for two dispensaries for which it had received approvals from Clark County and The City of Las Vegas. This puts the Company in a position similar to others who received state approval, but were denied or not yet approved by one or both of the other jurisdictions. It is unclear when, how, or if the inconsistencies between the state, city and county approvals will ultimately be resolved. While it would have been beneficial to have received the state dispensary approvals at this time, it does not detract from GB Sciences’ primary mission.

“Although we do not mean to understate the immediate commercial value of the cultivation license we were granted, our primary focus in obtaining the license was to enable the clinical research efforts we have planned, and to continue our other research initiatives into plant genetics, curing techniques, and the development of strains that are effective for particular diseases,” said GB Sciences, Inc., CEO Craig Ellins. “Without the license that was granted today, we could not pursue our mission of providing safe, consistent medication for the literally thousands of patients who need it. As a biopharmaceutical company, GB Sciences will create value through developing, patenting and branding innovative treatments; especially in ‘orphan’ disease categories where the ill have few if any treatment options.”
http://gbsciences.com/gb-sciences-las-vegas-cannabis-cultivation/




GB Sciences Partnerships

GB Sciences’ turnkey solutions facilitate entry into the emerging cannabinoid therapy marketplace. Our partners provide capital and local personnel, while we help them navigate through the state application process and set them up with our trademarked production and retail system. Our system is flexible and can be scaled to meet the needs of each partner’s local patient base.

Our Company

GrowBLOX Sciences, or GB Sciences, Inc. (OTCQB: GBLX), is a medical cannabis research and development company that offers solutions for the commercialization of cannabis and cannabis-based products to treat medical conditions and relieve their symptoms.

We are working hard to become the trusted brand of technology that empowers patients with access to the benefits of medicinal-grade cannabis, and to become the trusted producer of consistent and efficacious medicinal cannabis strains and product lines. Our products are manufactured with clinical, laboratory precision to ensure a high quality and consistency.

Significant milestones we have reached include:

Secured special use permits for a dispensary and cultivation facility in Clark County, Nevada
Filed for two dispensary locations in Las Vegas, Nevada
Secured Letter of Intent with First Security Bank of Nevada
Established subsidiary in Florida in anticipation for favorable upcoming legislative vote
Acquired 20% equity of LaurelCo LLC medical marijuana operations in Illinois and a 10% royalty on any products created with the GrowBLOX™


Key Projects in the Works

Finalizing a partnership in New York for dispensary and cultivation operations
Developing infrastructure in Puerto Rico in anticipation of favorable legislation
Obtaining FDA Approval of pharmaceutical product line

http://gbsciences.com/